Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma

Published:2021-08-25 Issue:4 Volume:9 Page:1596-1612
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immun Inflamm Dis

Author:

Qiu Yuqin¹^ORCID,Wang Xiaogang²,Fan Zhenjia¹,Zhan Shanhui¹,Jiang Xin¹,Huang Jinchang¹³

Affiliation:

1. Third Affiliated Hospital Beijing University of Chinese Medicine Beijing China

2. Department of Emergency Medicine, Beijing Haidian Hospital Haidian Section of Peking University Third Hospital Beijing China

3. Institute of Acupuncture and Moxibustion in Cancer Care Beijing University of Chinese Medicine Beijing China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.513

Reference63 articles.

1. Cancer Statistics, 2021

2. Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity

3. Renal cancer: new models and approach for personalizing therapy

4. Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma

5. The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16

2. m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p;2024-07-03

3. Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine;Frontiers in Pharmacology;2024-06-04

4. Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma;Discover Oncology;2024-05-26

5. Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response;Non-coding RNA Research;2024-03